HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Complement C3 mediates podocyte injury through TLR4/NFΚB-P65 signaling during ischemia-reperfusion acute kidney injury and post-injury fibrosis.

AbstractBACKGROUND:
The aim of this study was to explore the mechanism of complement C3a mediating podocyte injury during ischemia-reperfusion acute kidney injury (IR-AKI) and post-injury fibrosis.
METHODS:
Renal artery clamping was used to establish IR-AKI and post-injury fibrosis model. HE and Masson staining were performed to observe renal fibrosis. The protein abundance levels were measured along with inflammatory markers, renal complement C3. Podocytes were treated with C3a with or without Toll-like receptor 4(TLR4) inhibitor. The effects of TLR4 up-regulation by TLR4 plasmids were examined.
RESULTS:
C3-/- resulted in amelioration of renal dysfunction by reducing podocyte damage and renal fibrosis. Immunoblot with renal tissue homogenates from IR-AKI mice revealed that C3-/- decreased TLR4/Nuclear Factor-κB (NFκB)-P65.
CONCLUSION:
Our results indicate that modulating C3/TLR4/NFκB-P65 signaling pathway is a novel therapeutic target for the IR-AKI and post-injury fibrosis.
AuthorsYi Chen, Liyu Lin, Siyi Rao, Xuan Tao, Jiong Cui, Jianxin Wan
JournalEuropean journal of medical research (Eur J Med Res) Vol. 28 Issue 1 Pg. 135 (Mar 27 2023) ISSN: 2047-783X [Electronic] England
PMID36973754 (Publication Type: Journal Article)
Copyright© 2023. The Author(s).
Chemical References
  • Complement C3
  • Toll-Like Receptor 4
  • NF-kappa B
  • Tlr4 protein, mouse
Topics
  • Mice
  • Animals
  • Podocytes (metabolism, pathology)
  • Complement C3 (genetics, metabolism)
  • Toll-Like Receptor 4 (genetics, metabolism, therapeutic use)
  • Kidney (pathology)
  • Acute Kidney Injury (genetics, metabolism)
  • Signal Transduction
  • NF-kappa B (genetics, metabolism)
  • Reperfusion Injury (drug therapy)
  • Ischemia (metabolism, pathology)
  • Reperfusion
  • Fibrosis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: